Masimo Co. (NASDAQ:MASI) Holdings Decreased by Avior Wealth Management LLC

Avior Wealth Management LLC lessened its stake in Masimo Co. (NASDAQ:MASI) by 42.8% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,279 shares of the medical equipment provider’s stock after selling 2,452 shares during the period. Avior Wealth Management LLC’s holdings in Masimo were worth $542,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of MASI. American Century Companies Inc. boosted its holdings in shares of Masimo by 18.6% in the second quarter. American Century Companies Inc. now owns 10,671 shares of the medical equipment provider’s stock valued at $1,344,000 after acquiring an additional 1,671 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in Masimo by 45.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 525,594 shares of the medical equipment provider’s stock valued at $66,201,000 after purchasing an additional 165,257 shares in the last quarter. Marshall Wace LLP increased its position in shares of Masimo by 5.1% during the 2nd quarter. Marshall Wace LLP now owns 94,798 shares of the medical equipment provider’s stock valued at $11,939,000 after purchasing an additional 4,591 shares during the period. Squarepoint Ops LLC bought a new stake in shares of Masimo in the 2nd quarter worth $1,220,000. Finally, Deerfield Management Company L.P. Series C acquired a new stake in shares of Masimo in the second quarter valued at $233,000. Institutional investors and hedge funds own 85.96% of the company’s stock.

Masimo Stock Up 1.3 %

NASDAQ:MASI opened at $170.24 on Friday. The business’s fifty day moving average price is $170.32 and its 200 day moving average price is $142.40. The firm has a market capitalization of $9.11 billion, a price-to-earnings ratio of 117.41 and a beta of 1.01. The company has a current ratio of 2.01, a quick ratio of 1.11 and a debt-to-equity ratio of 0.50. Masimo Co. has a 1-year low of $101.61 and a 1-year high of $180.97.

Masimo (NASDAQ:MASI) last issued its earnings results on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share for the quarter, beating analysts’ consensus estimates of $0.84 by $0.14. Masimo had a return on equity of 14.98% and a net margin of 3.85%. The company had revenue of $504.60 million for the quarter, compared to the consensus estimate of $502.87 million. During the same quarter in the prior year, the company earned $0.63 EPS. The firm’s quarterly revenue was up 5.4% on a year-over-year basis. On average, sell-side analysts forecast that Masimo Co. will post 4.1 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently issued reports on the company. Piper Sandler lifted their target price on Masimo from $180.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, December 18th. Raymond James increased their target price on shares of Masimo from $170.00 to $194.00 and gave the company an “outperform” rating in a research note on Friday, December 27th. BTIG Research lifted their price target on shares of Masimo from $166.00 to $170.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. Stifel Nicolaus reiterated a “buy” rating and set a $190.00 price objective (up previously from $170.00) on shares of Masimo in a research report on Friday, November 22nd. Finally, Wells Fargo & Company raised their price objective on Masimo from $171.00 to $193.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 11th. Three investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $179.67.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.